WO2011088209A2
|
|
1-deoxy analogs of vitamin d-related compounds
|
WO2010083613A1
|
|
Phosphate management with small molecules
|
EP2376508A1
|
|
Method for synthesizing vitamin d analogs
|
CA2714996A1
|
|
Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
|
WO2009111873A1
|
|
Stabilized 1,25-dihydroxyvitamin d2 and method of making same
|
WO2008146130A1
|
|
Process for producing phosphine oxide vitamin d precursors
|
CA2683628A1
|
|
Method of treating vitamin d insufficiency and deficiency
|
EP2762132A1
|
|
Controlled Release 25-Hydroxyvitamin D
|
EP2148685A2
|
|
Methods and compounds for vitamin d therapy
|
US2005208055A1
|
|
Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof
|
AU2003222699A1
|
|
Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof
|
US7335756B2
|
|
Retinoic acid metabolizing cytochrome P450
|
AU2002231531A1
|
|
Cloning and characterization of a human cytochrome p450, cyp 27c1, and a hybrid homolog from xenopus laevis
|
US7115558B2
|
|
P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
|
AU1577602A
|
|
P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods anduses thereof
|
CA2431640A1
|
|
P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
|
MXPA02010267A
|
|
A thymus expressed human cytochrome p450 (p450tec).
|
CA2396511A1
|
|
Cytochrome p450rai-2 and related proteins
|